HUT62197A - Process for producing pharmaceutical compositions comprising fibroblast growth factor for preventing and treating viral infections - Google Patents
Process for producing pharmaceutical compositions comprising fibroblast growth factor for preventing and treating viral infections Download PDFInfo
- Publication number
- HUT62197A HUT62197A HU913022A HU302291A HUT62197A HU T62197 A HUT62197 A HU T62197A HU 913022 A HU913022 A HU 913022A HU 302291 A HU302291 A HU 302291A HU T62197 A HUT62197 A HU T62197A
- Authority
- HU
- Hungary
- Prior art keywords
- fibroblast growth
- growth factor
- virus
- use according
- viral infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT02280489A IT1237795B (it) | 1989-12-22 | 1989-12-22 | Fattori di crescita fibroblastici per l'uso nella prevenzione e nel trattamento di infezioni virali. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU913022D0 HU913022D0 (en) | 1992-01-28 |
| HUT62197A true HUT62197A (en) | 1993-04-28 |
Family
ID=11200616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU913022A HUT62197A (en) | 1989-12-22 | 1990-12-18 | Process for producing pharmaceutical compositions comprising fibroblast growth factor for preventing and treating viral infections |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0460161A1 (it) |
| JP (1) | JPH04504581A (it) |
| AU (1) | AU632890B2 (it) |
| CA (1) | CA2047203A1 (it) |
| HU (1) | HUT62197A (it) |
| IE (1) | IE904593A1 (it) |
| IL (1) | IL96667A0 (it) |
| IT (1) | IT1237795B (it) |
| WO (1) | WO1991009610A1 (it) |
| ZA (1) | ZA9010337B (it) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5714458A (en) * | 1990-07-18 | 1998-02-03 | Farmitalia Carlo Erba S.R.L. | Stable pharmaceutical compositions containing a fibroblast growth factor |
| DE60133767T2 (de) | 2000-11-27 | 2009-06-25 | Dnavec Research Inc., Tsukuba | Für fibroblasten-wachstumsfaktor 2 (fgf2) kodierender paramyxovirus-vektor und dessen verwendung |
| JP6363833B2 (ja) * | 2013-11-22 | 2018-07-25 | ナノシータ株式会社 | 薄膜状高分子構造体 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3689845T3 (de) * | 1985-09-12 | 2001-11-15 | Scios Inc., Sunnyvale | Rekombinanter fibroblast-wachstumsfaktor. |
| US4929442A (en) * | 1986-09-26 | 1990-05-29 | Exovir, Inc. | Compositions suitable for human topical application including a growth factor and/or related materials |
-
1989
- 1989-12-22 IT IT02280489A patent/IT1237795B/it active IP Right Grant
-
1990
- 1990-12-14 IL IL96667A patent/IL96667A0/xx unknown
- 1990-12-18 AU AU69704/91A patent/AU632890B2/en not_active Ceased
- 1990-12-18 CA CA002047203A patent/CA2047203A1/en not_active Abandoned
- 1990-12-18 JP JP3501675A patent/JPH04504581A/ja active Pending
- 1990-12-18 EP EP91901282A patent/EP0460161A1/en active Pending
- 1990-12-18 WO PCT/EP1990/002231 patent/WO1991009610A1/en not_active Ceased
- 1990-12-18 HU HU913022A patent/HUT62197A/hu unknown
- 1990-12-19 IE IE459390A patent/IE904593A1/en unknown
- 1990-12-21 ZA ZA9010337A patent/ZA9010337B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04504581A (ja) | 1992-08-13 |
| IT8922804A0 (it) | 1989-12-22 |
| IL96667A0 (en) | 1991-09-16 |
| AU632890B2 (en) | 1993-01-14 |
| ZA9010337B (en) | 1991-10-30 |
| IE904593A1 (en) | 1991-07-03 |
| IT8922804A1 (it) | 1991-06-22 |
| HU913022D0 (en) | 1992-01-28 |
| CA2047203A1 (en) | 1991-06-23 |
| EP0460161A1 (en) | 1991-12-11 |
| WO1991009610A1 (en) | 1991-07-11 |
| AU6970491A (en) | 1991-07-24 |
| IT1237795B (it) | 1993-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5288704A (en) | Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent | |
| AU617126B2 (en) | A polypeptide growth factor from milk | |
| KR20010033484A (ko) | 각질세포 성장 인자-2 제제 | |
| JPH10509428A (ja) | 活性依存性神経栄養因子の神経栄養ペプチド | |
| CA2375829A1 (en) | Keratinocyte growth factor-2 formulations | |
| US5763406A (en) | Method for the treatment of conditions caused by herpes virus infections | |
| KR20180099546A (ko) | 에리스로포이에틴 유래 펩티드의 세포손상방지에 효과를 통한 활용 | |
| CN102336815A (zh) | 病毒感染的治疗 | |
| JPH0625007A (ja) | Hbnfおよびmkタンパク質を使用するウイルスの感染を処置および阻止する方法 | |
| CN114773428A (zh) | 新多肽及其在制备治疗皮肤创面或黏膜损伤药物中的应用 | |
| IE65533B1 (en) | Hemoregulatory peptides | |
| US6017880A (en) | Inhibition of retrovirus infection | |
| US5534495A (en) | Treatment of non-HIV neuropathic pain syndromes | |
| AU632890B2 (en) | Fibroblast growth factor for use in the prevention and treatment of viral infections | |
| CN117157308A (zh) | 细胞穿膜肽变体及其用途 | |
| DE69332904T2 (de) | Hemmung von hiv-infektion | |
| US6869925B1 (en) | Inhibition of retrovirus infection | |
| WO1992021362A1 (en) | Nerve growth factor for use in the prevention and treatment of viral infections | |
| CA2202496C (en) | Neurotrophic peptides of activity dependent neurotrophic factor | |
| EP0557319B1 (en) | Therapeutic use of fibroblast growth factor | |
| JP2838867B2 (ja) | 幹細胞増殖促進剤 | |
| US8178497B2 (en) | Method of treating HIV in drug resistant non plasma viral reservoirs with monomeric DAPTA | |
| JPH0820599A (ja) | 新規なタンパク質 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFD9 | Temporary protection cancelled due to non-payment of fee |